1. DRD2 antagonizes YAP-dependent fibrotic crosstalk promoting liver regeneration over fibrosis;2. DRD2 antagonists block fibrosis and restore liver architecture in rodent and large animal models of NASH. This evidence concerns the gene DRD2 and metabolic dysfunction-associated steatohepatitis.